Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients

Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients

(2016) L Michel et al.   BONE MARROW TRANSPLANTATION

An engineered multicomponent bone marrow niche for the recapitulation of hematopoiesis at ectopic transplantation sites

(2016) Mónica S. Ventura Ferreira et al.   Journal of Hematology & Oncology

The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation

(2016) Ke Zhao et al.   Journal of Hematology & Oncology

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery

(2016) Michael M. B. Green et al.   Journal of Hematology & Oncology

Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases

(2016) L.C.M. Arruda et al.   Current Research in Translational Medicine

The roles of stem cell memory T cells in hematological malignancies

(2015) Ling Xu et al.   Journal of Hematology & Oncology

SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking

(2014) T Alexander et al.   BONE MARROW TRANSPLANTATION

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

(2014) Jacob M. van Laar et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

(2013) Frank van den Hoogen et al.   ARTHRITIS AND RHEUMATISM

Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study

(2013) J Baraut et al.   BONE MARROW TRANSPLANTATION

Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis

(2013) Richard K Burt et al.   LANCET

Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres

(2011) J. Fransen et al.   ANNALS OF THE RHEUMATIC DISEASES

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

(2011) J A Snowden et al.   BONE MARROW TRANSPLANTATION

Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial

(2011) Richard K Burt et al.   LANCET

Analysis of immune reconstitution after autologous CD34+ stem/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells

(2010) H. Tsukamoto et al.   RHEUMATOLOGY

Immune re-education following autologous hematopoietic stem cell transplantation

(2008) Sofia Abrahamsson et al.   AUTOIMMUNITY

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system

(2008) T. Alexander et al.   BLOOD

Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis

(2007) M C Vonk et al.   ANNALS OF THE RHEUMATIC DISEASES